<< Back to Investments

Medical Marijuana Inc.

Medical Marijuana Inc. (OTC: MJNA) is the first publicly held legal cannabis and industrial hemp company in the world. Acquired by the founding partners of General Hemp™ in 2009, Medical Marijuana Inc. is comprised of a diverse portfolio of products, services, technologies and businesses focused on the production of cannabidiol (CBD) hemp oil products. Medical Marijuana Inc. leverages their team of professionals to source, evaluate, and purchase value-added companies and products, all while allowing them to keep their integrity and entrepreneurial spirit.

Connect


12975 Brook Printer Pl Suite 160
Poway, California 92064
United States of America
(888) OTC-MJNA
Contact
www.medicalmarijuanainc.com

June 19, 2017

Medical Marijuana, Inc. Garners National News Coverage at 4th Annual Cannabis World Congress and Business Expo in New York

Getty Images, NBC News segment highlight articles and TV interviews about Company’s CBD hemp oil; feature executives speaking on burgeoning industry. SAN DIEGO, June 19, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States,

June 12, 2017

Medical Marijuana, Inc. Subsidiary Kannaway® Recognizes First Brand Ambassadors to Achieve National Director Title

SAN DIEGO, June 12, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Kannaway, LLC, the first hemp lifestyle network to offer phyto-cannabinoid botanical products, is recognizing its first Brand Ambassadors to reach the Company’s National Director Rank. Jeff and

May 22, 2017

Medical Marijuana, Inc. Strengthens Europe Leadership Team With Appointment of Alex Grapov As International Vice President

SAN DIEGO, May 22, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that it has appointed Alex Grapov as its International Vice President. Grapov’s first priority will be to open Medical Marijuana Inc. subsidiary  Kannaway LLC‘s Kannaway® Europe operation. Kannaway®, the first

May 16, 2017

Medical Marijuana, Inc. Subsidiary HempMeds® to Showcase the Benefits of CBD Oil Products at Panama Women’s Medical Conference

SAN DIEGO, May 16, 2017 — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® will bring their knowledge of the benefits from its line of CBD hemp oil supplements into

May 9, 2017

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Expansion into Europe, Appoints New Operations Director

Portfolio Company and First Hemp Lifestyle Network to Establish Kannaway® Europe SAN DIEGO, May 9, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Kannaway, LLC, the first hemp lifestyle network to offer phyto-cannabinoid botanical products, is expanding

May 8, 2017

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Increased Profitability, 11X Growth In 13 Months

SAN DIEGO, May 8, 2017 /PRNewswire/ — Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary, Kannaway®, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has

May 5, 2017

Medical Marijuana Inc. Now Sells Vaporizers to Expand Upon World-Renowned Product Offerings

New Vaporizer Line is Company’s Latest Vehicle for Healthy Consumption of Dry Herbs and Concentrates SAN DIEGO, May 5, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, announced today that it has

May 4, 2017

Medical Marijuana, Inc. Featured in Entrepreneur Magazine Article Highlighting Company’s Unique Innovations in Hemp Cannabidiol (CBD) Products

Article from One of World’s Top Business Magazines Highlights Innovation and Growth of Medical Marijuana, Inc. in Mexico and the U.S. SAN DIEGO, May 4, 2017 — Medical Marijuana, Inc. (OTC-PINK:MJNA), the first publicly traded cannabis company in the United

May 2, 2017

Medical Marijuana, Inc. Reports Year End 2016 Financial Results and Operational Highlights – Product Sales by Quarter Increased 66% Q1-Q4

SAN DIEGO, May 2, 2017 — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, today announced financial results for the quarter and year ending December 31, 2016, and provided an overview of recent operational

April 27, 2017

Medical Marijuana, Inc. Subsidiary Kannaway® Announces First-Ever East Coast Red Carpet Event in New York

Portfolio Company and First Hemp Lifestyle Network Comes to New York to Discuss Opportunities to Become Involved in Booming CBD Industry SAN DIEGO, April 27, 2017 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States,

April 21, 2017

Medical Marijuana, Inc. Subsidiary HempMeds® to Sponsor and Exhibit at San Diego EarthFair 2017

SAN DIEGO, April 21, 2017 — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® is sponsoring San Diego EarthWork’s 28th annual EarthFair event. EarthFair 2017 will take place from 10

April 20, 2017

Medical Marijuana, Inc. Subsidiary HempMeds® to Sponsor and Exhibit at 2017 World Medical Cannabis Conference and Expo

CEO to Speak on Industrial Hemp Opportunities; Medical Marijuana, Inc. PR Firm CMW Media Also Hosting “Children and Cannabis” Panel SAN DIEGO, April 20, 2017 — Medical Marijuana, Inc. ( MJNA ), the first publicly traded cannabis company in the

March 21, 2017

Medical Marijuana, Inc. Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications

NEW YORK, March 21, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM®Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, has

March 7, 2017

Medical Marijuana, Inc. Investment AXIM® Biotech Announces Enrolled Patients Begin Phase II Trial For The Treatment Of Irritable Bowel Syndrome (IBS) With CanChew Plus® Cannabidiol (CBD) Chewing Gum

NEW YORK, March 7, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has enrolled 40 patients and commenced its Phase

February 9, 2017

Medical Marijuana, Inc. CEO To Speak On Cannabis Industry Trends & Cannabinoid-Based Pharmaceuticals At Money Show Orlando

SAN DIEGO, Feb. 8, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that at The Money Show Orlando, Medical Marijuana, Inc., Chief Executive Officer, Dr. Stuart Titus, will speak to investors

January 24, 2017

Medical Marijuana, Inc. Subsidiary HempMeds Mexico® Receives COFEPRIS Permission for Flagship Product RSHO-X™ Usage for Cancer Patient

Patient Received Permission to Be Treated with RSHO-X™ for Pain Associated with Cancer Treatment and General Well-Being SAN DIEGO, Jan. 24, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds Mexico® has received permission from Mexico’s

January 23, 2017

Medical Marijuana, Inc. Featured in International Business Times Article Highlighting RSHO-X and the State of the Global Cannabis Industry

Dr. Stuart Titus Speaks on RSHO-X’s Benefits and Cannabis Industry Updates Around the World SAN DIEGO, Jan. 23, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, was recently featured in an

January 13, 2017

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Atlanta, Georgia

Portfolio Company and First Hemp Lifestyle Network to Offer Cannabidiol (CBD) Products to Give Sneak Peak on New Products, Brand and Incentives SAN DIEGO, Jan. 13, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA) announced today that its subsidiary, Kannaway LLC, the

January 11, 2017

Phoenix TV, One of China”s Largest TV Networks, Features Interviews with Medical Marijuana, Inc. CEO Stuart Titus Discussing the Economic Impact of CBD Products

Interview Portrays the Benefits of Cannabis-Related Products to Millions of Chinese Viewers Around the World SAN DIEGO, Jan. 11, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA) is pleased to announce that the Company’s CEO was featured in a series of interviews

January 10, 2017

AXIM® Biotech Attends Biotech Showcase and J.P. Morgan Healthcare Conferences in San Francisco

NEW YORK, Jan 10, 2017 — AXIM Biotechnologies, Inc. (AXIM Biotech) AXIM, +23.30% a world leader in cannabinoid research and development, today announced that George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM Biotech, is meeting with

Medical Marijuana Inc. focuses on the capitalization, development and acquisition of hemp and medicinal hemp based consumer products as well as the supporting technologies.